An estradiol result for a man means very little without knowing the assay. At Longevity Benchmark, we review hormone panels to see whether the testing technology matches clinical standards. Most routine blood work uses an automated immunoassay. Because men circulate low estrogen concentrations, that standard platform often produces misleading data on estradiol levels in men.
The Verdict
Which Estradiol Test Produced the Number
The laboratory method determines whether a male estradiol result is reliable. The Association for Diagnostics & Laboratory Medicine (ADLM) publishes optimal testing guidance for clinical practice. Their guidance directly advises against ordering estradiol by immunoassay on men, children, and postmenopausal women. Instead, ADLM states that male estradiol testing should use liquid chromatography-tandem mass spectrometry (LC-MS/MS).
The technical limitation involves concentration. Immunoassays perform best at higher hormone levels. They work well within female physiological ranges. In adult men, estrogens circulate at concentrations below about 20 pg/mL. Direct immunoassays lose analytical specificity in this lower concentration band. A study in Cancer Epidemiology, Biomarkers & Prevention from the American Association for Cancer Research (AACR) describes this exact issue. Other circulating molecules cross-react with immunoassay antibodies. Mass spectrometry eliminates that interference.
What the Published Reference Interval Says
An accurate reference interval for male estradiol requires mass-spectrometry data from healthy populations. A 2019 study in the Journal of Clinical Endocrinology & Metabolism (JCEM) established such an interval. Researchers analyzed 157 men aged 31.4 to 60.9 years from the Health2008 cohort at Glostrup University Hospital in Denmark. Their LC-MS/MS analysis established a normal reference interval of 50 to 150 pmol/L for men aged 30 to 60.
Hormone laboratories report results in different units. Converting between these systems is straightforward. Multiplying a value in pmol/L by 0.2724 yields picograms per milliliter (pg/mL). Applying that formula to the Danish cohort data produces a reference interval of roughly 14 to 41 pg/mL. This conversion lets you evaluate your numbers against published evidence. The interval floor sits below 20 pg/mL. Because immunoassay unreliability begins below about 20 pg/mL, some healthy men fall into that unmeasurable zone. This overlap is why the assay name has to appear on the report.
| Unit of Measurement | Lower Limit | Upper Limit | Reference Population |
|---|---|---|---|
| Picomoles per Liter (pmol/L) | 50 pmol/L | 150 pmol/L | 157 men aged 31.4 to 60.9 years (Health2008 cohort) |
| Picograms per Milliliter (pg/mL) | 14 pg/mL | 41 pg/mL | Calculated using 0.2724 conversion factor from LC-MS/MS data |
Why a Reference Interval Belongs to an Assay
A laboratory reference interval belongs strictly to the assay that produced it, not to the hormone itself. The authors of the 2019 JCEM study addressed this analytical principle directly. They noted that most previously published male estradiol numbers derived from immunoassays are likely inaccurate. Different immunoassay platforms show marked variation in their results, particularly at low concentrations.
Immunoassay values cannot be transferred to mass-spectrometry scales. The same printed number from two platforms does not mean the same concentration. Our guide to normal vs optimal biomarkers explores why reference ranges shift between testing platforms. Laboratories set ranges based on their internal testing equipment. You can explore other hormone tests in our biomarkers directory to see how testing methodologies influence laboratory ranges. Checking the method on past results prevents false assumptions when monitoring trends over time.
What Estradiol Actually Does in Men
Estradiol performs distinct physiological functions in men rather than serving as an inert metabolic byproduct. A landmark 2013 study in The New England Journal of Medicine (NEJM) by Finkelstein and colleagues mapped these specific biological roles. The researchers enrolled 400 healthy men aged 20 to 50. All participants received goserelin acetate to suppress natural testosterone production.
Cohort 1 comprised 198 men who received placebo or one of four testosterone gel doses. Cohort 2 enrolled 202 men who received identical testosterone doses plus anastrozole. Anastrozole prevented testosterone from converting into estradiol. Comparing these groups revealed distinct hormonal duties. Estrogen deficiency primarily accounted for increases in body fat. Androgen deficiency accounted for decreases in lean mass, muscle size, and strength. Both androgens and estrogens contributed to the maintenance of sexual function. Suppressing estradiol led to adverse changes in body composition. Men need sufficient estrogen for metabolic health.
How Testosterone Shapes Estradiol Levels in Men
Most circulating estradiol in men comes from the enzymatic aromatisation of testosterone. The aromatase enzyme converts a fraction of circulating testosterone directly into estradiol. Because of this shared pathway, estradiol levels in men typically track circulating testosterone concentrations. Higher testosterone availability provides more substrate for aromatase. This metabolic relationship explains why clinicians evaluate both hormones concurrently.
In the 2013 NEJM study, anastrozole blocked this aromatase conversion in Cohort 2. That design let the researchers separate what testosterone does from what estradiol does. When evaluating hormone panels, clinicians evaluate free vs total testosterone alongside total circulating estrogen. Proteins also matter. Circulating sex hormone-binding globulin (SHBG) binds both testosterone and estradiol in the bloodstream. This binding activity determines how much free hormone remains biologically active. Aromatisation remains the primary mechanism controlling male estradiol production.
When Laboratory Guidance Recommends Estradiol Testing
The Association for Diagnostics & Laboratory Medicine defines three primary clinical indications for evaluating male estradiol. First, testing evaluates symptoms of estradiol excess. Gynecomastia, the development of enlarged glandular breast tissue, represents the primary clinical presentation of excess estrogen. Second, clinicians measure estradiol when assessing steroid-secreting adrenal, hepatic, or testicular tumours. Third, testing investigates suspected estradiol deficiency.
In addition to these three indications, ADLM guidance notes that estradiol may be monitored in men receiving testosterone replacement therapy (TRT). Testosterone therapy adds more of the raw material the enzyme works on, which is why estradiol is commonly checked alongside it. Reviewing a broader men's hormone panel provides context for these shifts. If you take testosterone, consult our overview of TRT side effects and risks to understand related lab markers. Testing should always align with documented clinical goals.
What Estradiol Levels in Men Cannot Reveal Alone
A male estradiol reading cannot establish an individual treatment target or dictate medical therapy on its own. The published reference intervals describe what was measured in a sampled group of Danish men. They do not define an ideal target for every individual. No clinical trial on this page established a specific estradiol number to aim for. Furthermore, the evidence here did not evaluate interventions for raising or lowering estrogen levels.
Blood concentrations alone cannot confirm symptom causes. The Finkelstein trial demonstrated functional consequences of severe deficiency, but did not test wellness treatments. This page is not for men managing diagnosed adrenal, testicular, or hepatic tumours that require specialized hospital protocols. Our assessment of immunoassays would change if peer-reviewed trials proved reliable analytical specificity below 20 pg/mL. Clinical context matters more than an isolated number.
Questions to Ask When Reviewing a Panel
Reviewing your laboratory report requires asking specific methodological questions rather than focusing solely on the reported number. A low or elevated result carries no diagnostic value if the underlying testing platform lacks specificity. Clinicians and patients can clarify ambiguous results by reviewing four specific questions:
- Assay methodology. Which specific assay technology did the laboratory use to analyze this blood sample?
- Platform type. Was this estradiol measured using an LC-MS/MS platform or an automated direct immunoassay?
- Reference standards. Does the reference interval printed on the report come from male mass-spectrometry cohorts or female immunoassay ranges?
- Reporting units. Is the measurement expressed in picograms per milliliter (pg/mL) or picomoles per liter (pmol/L)?
Frequently Asked Questions
What is a normal estradiol level in men?
A normal reference interval for estradiol in men aged 30 to 60 is 50 to 150 pmol/L, which converts to approximately 14 to 41 pg/mL. This interval was established by a 2019 study in the Journal of Clinical Endocrinology & Metabolism evaluating 157 healthy men using liquid chromatography-tandem mass spectrometry (LC-MS/MS). These figures describe what was measured in that specific cohort rather than an individual treatment target. Reference intervals belong strictly to the laboratory technology that generated them. If your test used a standard immunoassay rather than mass spectrometry, your result cannot be accurately compared against this published interval.
What is a sensitive estradiol test?
A sensitive estradiol test is a laboratory assay that uses liquid chromatography-tandem mass spectrometry (LC-MS/MS) to measure low circulating concentrations of estrogen. Standard automated immunoassays rely on antibody binding, which works well in adult women but loses analytical specificity at the lower concentrations found in men. An LC-MS/MS platform physically separates steroid molecules before measuring their specific mass. This process prevents cross-reactivity from other circulating steroids. Professional laboratory guidelines recommend sensitive mass-spectrometry assays for men, children, and postmenopausal women to ensure reported numbers reflect true hormone concentrations.
Should men get estradiol tested by immunoassay?
Men should not have estradiol measured by immunoassay according to optimal-testing guidance from the Association for Diagnostics & Laboratory Medicine (ADLM). The ADLM explicitly advises against ordering estradiol or other estrogens by immunoassay in men, children, and postmenopausal women. Immunoassays perform best at higher hormone concentrations and lose specificity below roughly 20 pg/mL, a range where many men naturally circulate. In this lower range, cross-reactivity with other circulating steroids frequently distorts immunoassay results. Clinicians should specifically request liquid chromatography-tandem mass spectrometry (LC-MS/MS) for male estradiol testing.
What are the symptoms of high estrogen in men?
Gynecomastia, the development of enlarged glandular breast tissue, is the primary symptom of estradiol excess recognized in laboratory testing guidelines. The Association for Diagnostics & Laboratory Medicine lists the evaluation of symptoms of excess, presenting primarily as gynecomastia, as a core indication for testing. The clinical trials and laboratory guidelines reviewed on this page do not support a broader symptom checklist. Because symptoms cannot confirm a hormone imbalance on their own, physical presentations of estradiol excess require clinical evaluation alongside sensitive mass-spectrometry blood testing.
Do men need estrogen?
Men require estrogen for critical physiological functions including the maintenance of healthy body fat and sexual function. A landmark 2013 study in The New England Journal of Medicine found that estrogen deficiency primarily accounted for increases in body fat. While androgen deficiency drove declines in lean mass and muscle size, both androgens and estrogens were found to support normal sexual function. Estradiol is not an unwanted metabolic byproduct in the male body. It is an active steroid hormone that contributes to male metabolic balance.
Why is my estradiol high on TRT?
Estradiol often rises during testosterone replacement therapy (TRT) because circulating testosterone converts directly into estradiol through the aromatase enzyme. When testosterone therapy increases total circulating androgen levels, more hormonal substrate becomes available for this enzymatic conversion. Clinical testing guidelines from the Association for Diagnostics & Laboratory Medicine note that estradiol may be monitored in men receiving testosterone replacement therapy. Evaluating changes on TRT requires verifying that your laboratory used a sensitive mass-spectrometry assay to ensure the elevated reading is analytically valid.
Is estradiol measured in pg/mL or pmol/L?
Estradiol is reported in both picograms per milliliter (pg/mL) and picomoles per liter (pmol/L), depending on the laboratory and country. In the United States, labs commonly report in pg/mL, whereas international studies frequently report in pmol/L. You can convert between these systems using a standard conversion factor: multiply pmol/L by 0.2724 to calculate pg/mL, or divide pg/mL by 0.2724 to find pmol/L. For example, the published LC-MS/MS reference interval of 50 to 150 pmol/L equals approximately 14 to 41 pg/mL.